Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Determinants of adherence to glaucoma medical therapy in a long-term patient population.

Djafari F, Lesk MR, Harasymowycz PJ, Desjardins D, Lachaine J.

J Glaucoma. 2009 Mar;18(3):238-43. doi: 10.1097/IJG.0b013e3181815421.

PMID:
19295380
2.

Persistence and adherence with topical glaucoma therapy.

Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM.

Am J Ophthalmol. 2005 Oct;140(4):598-606.

PMID:
16226511
3.

Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.

Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS.

Ophthalmology. 2009 Feb;116(2):191-9. doi: 10.1016/j.ophtha.2008.09.004. Epub 2008 Dec 12.

PMID:
19084273
4.

Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.

Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS.

Am J Ophthalmol. 2007 Oct;144(4):533-40. Epub 2007 Aug 8.

PMID:
17686450
5.

Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.

Quigley HA, Friedman DS, Hahn SR.

Ophthalmology. 2007 Sep;114(9):1599-606. Epub 2007 Jun 18.

PMID:
17572498
6.

Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.

Flowers B, Wand M, Piltz-Seymour J, Berke SJ, Day D, Teague J, Smoot TM, Landry TA, Bergamini MV, Mallick S; Travatan Dosing Aid Study Group.

Clin Ther. 2006 Nov;28(11):1803-11.

PMID:
17213000
7.

Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.

McCarty CA, Mukesh BN, Kitchner TE, Hubbard WC, Wilke RA, Burmester JK, Patchett RB.

J Glaucoma. 2008 Aug;17(5):372-7. doi: 10.1097/IJG.0b013e31815c5f3f.

PMID:
18703947
8.

Treatment of glaucoma patients with insufficient intraocular pressure control: a survey of German ophthalmologists in private practice.

Vorwerk C, Thelen U, Buchholz P, Kimmich F.

Curr Med Res Opin. 2008 May;24(5):1295-301. doi: 10.1185/030079908X291976 . Epub 2008 Mar 25.

PMID:
18366862
9.

Health literacy and adherence to glaucoma therapy.

Muir KW, Santiago-Turla C, Stinnett SS, Herndon LW, Allingham RR, Challa P, Lee PP.

Am J Ophthalmol. 2006 Aug;142(2):223-6.

PMID:
16876500
10.

Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.

Friedman DS, Hahn SR, Gelb L, Tan J, Shah SN, Kim EE, Zimmerman TJ, Quigley HA.

Ophthalmology. 2008 Aug;115(8):1320-7, 1327.e1-3. doi: 10.1016/j.ophtha.2007.11.023. Epub 2008 Mar 5.

PMID:
18321582
11.

Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).

Vandenbroeck S, De Geest S, Dobbels F, Fieuws S, Stalmans I, Zeyen T.

J Glaucoma. 2011 Sep;20(7):414-21. doi: 10.1097/IJG.0b013e3181f7b10e.

PMID:
21048510
12.

Accounting for restart rates in evaluating persistence with ocular hypotensives.

Schwartz GF, Platt R, Reardon G, Mychaskiw MA.

Ophthalmology. 2007 Apr;114(4):648-52.

PMID:
17398318
13.

Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.

Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Quigley HA.

Ophthalmology. 2009 Jun;116(6):1097-105. doi: 10.1016/j.ophtha.2009.01.021. Epub 2009 Apr 19.

PMID:
19376591
14.

Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).

Friedman DS, Quigley HA, Gelb L, Tan J, Margolis J, Shah SN, Kim EE, Zimmerman T, Hahn SR.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5052-7.

PMID:
17962457
15.

Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?

Robin AL, Covert D.

Ophthalmology. 2005 May;112(5):863-8.

PMID:
15878067
16.

Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.

Wilensky J, Fiscella RG, Carlson AM, Morris LS, Walt J.

Am J Ophthalmol. 2006 Jan;141(1 Suppl):S28-33.

PMID:
16389058
17.

Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.

Jayawant SS, Bhosle MJ, Anderson RT, Balkrishnan R.

J Glaucoma. 2007 Sep;16(6):513-20.

PMID:
17873711
18.

Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002.

Stein JD, Ayyagari P, Sloan FA, Lee PP.

Ophthalmology. 2008 Aug;115(8):1315-9, 1319.e1. doi: 10.1016/j.ophtha.2007.12.017. Epub 2008 Mar 5.

PMID:
18321581
19.

Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Olthoff CM, Hoevenaars JG, van den Borne BW, Webers CA, Schouten JS.

Graefes Arch Clin Exp Ophthalmol. 2009 Feb;247(2):235-43. doi: 10.1007/s00417-008-0944-y. Epub 2008 Sep 19.

PMID:
18802720
20.

An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.

Martone G, Frezzotti P, Tosi GM, Traversi C, Mittica V, Malandrini A, Pichierri P, Balestrazzi A, Motolese PA, Motolese I, Motolese E.

Am J Ophthalmol. 2009 Apr;147(4):725-735.e1. doi: 10.1016/j.ajo.2008.10.019. Epub 2009 Feb 1.

PMID:
19181302

Supplemental Content

Support Center